Rite Aid (RAD) Tops Q4 EPS by 5c; Comps Rose 4.5%

Rite Aid (NYSE: RAD) reported Q4 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $6.85 billion versus the consensus estimate of $6.79 billion.

Same store sales for the quarter increased 4.5 percent over the prior year, consisting of a 5.7 percent increase in pharmacy sales and a 2.0 percent increase in front-end sales. Pharmacy sales included a negative impact of approximately 128 basis points from new generic introductions. The number of prescriptions filled in same stores increased 3.5 percent over the prior year period. Prescription sales accounted for 68.1 percent of total drugstore sales, and third party prescription revenue was 97.5 percent of pharmacy sales.

Rite Aid sees FY2015 EPS of $0.19 - $0.27, versus the consensus of $0.35. This guidance is net of estimated income tax expense of between $130 million and $180 million, or $0.13 to $0.18 per diluted share, respectively.

Rite Aid sees FY2015 revenue of $26.9 - $27.4 million, versus the consensus of $26.5 million.

For earnings history and earnings-related data on Rite Aid (RAD) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results